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Abstract
Background: Evidence from animal studies suggests that leptin metabolism is associatedwith zinc (Zn) status.
However, research investigating this relationship in adolescents and young adults with anorexia nervosa (AN)
is scarce; the present study aims to fill that gap.
Methods: Serum concentrations of leptin, the soluble leptin receptor (sOB-R) and the free leptin index (FLI)
were obtained in healthy control subjects (n19), acutely ill individuals (n14) and recovered patients with
AN (n15). Serum Zn concentrations noted in previous research data were also incorporated for all groups.
Results: Leptin, FLI and Zn concentrations were higher in recovered subjects with AN when compared with
acutely ill AN patients. Remitted patients showed higher sOB-R concentrations but no difference in FLI
compared with the control group. Leptin and FLI were lower in the acutely ill patients compared with the
control subjects, who showed no differences in Zn concentrations. Zn concentrations were not correlated with
leptin, sOB-R or FLI concentrations in any of the three investigated subgroups.
Conclusions: The present investigation does not entirely support an association between Zn, Leptin and FLI
concentrations in subjects with AN, possibly due to limited statistical power. Further research and replication
of the present findings related to the interaction between leptin and Zn is warranted. However, with respect to
serum leptin levels the data of the present investigation indicate that acutely ill and remitted patients with AN
differ as regards serum leptin concentrations and FLI, which is in line with previous research.
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P
ast research has indicated that the hormone leptin
is a major player when it comes to triggering the
adaption of the human body to severely restricted
food intake (13). Studies focusing on the regulation of
leptin levels during a zinc (Zn) deficiency showed that
circulating leptin concentrations are diminished during
Zn deficiency in rats and humans (4, 5). There seem to be
two mechanisms responsible for this phenomenon: a
decrease in the amount of leptin produced per gram of
adipose tissue (6), and an overall reduction in body fat
during Zn deficiency (7). With respect to previous
findings, marginal Zn deficiency in rats decreased leptin
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corticotrophin-releasing hormone in relation to food
intake (8), suggesting that leptin expression may be
directly affected by Zn. Further research suggests that
decreased food intake, rather than Zn deficiency itself,
is associated with changes in plasma leptin, metabolic
rate and activity levels in Zn deficient rats; thus, it seems
that low serum leptin concentrations, hypometabolism,
and decreased activity are more likely the result of
anorexia than of Zn deficiency per se (9, 10). However,
data investigating this relationship in adolescent humans
and young adults with anorexia nervosa (AN) do not
exist.
Research has indicated that the free leptin index (FLI)
is a valuable tool for investigating the leptin axis during
growth and sexual maturation (11). FLI is calculated
using the ratio of leptin to the soluble leptin receptor
(sOB-R). In human blood, leptin is bound by a high-
affinity binding protein; this particular protein appears to
be identical to the sOB-R. We previously reported
differences in serum Zn concentrations between remitted
and acutely ill patients with AN (12), with elevated serum
Zn concentrations in remitted patients. This difference
was most likely linked to reported dietary preferences, in
particular as regards Ca
2 and phosphorus containing
foods which can influence absorption of Zn.
Ca
2 and phosphate can decrease Zn absorption, and
previousfindings in this sample demonstrated that acutely
ill patients had higher serum Ca
2 and inorganic phos-
phate concentrationswhen compared tocontrols, andalso
preferred foods containing Ca
2 and phosphorus (12).
In view of the expected correlation between altered
serum leptin levels and Zn metabolism, we aimed to
investigate potential interactions between Zn status and
the leptin axis in acutely ill and remitted AN patients in
comparison with healthy controls. The data on Zn
concentrations referred to in this paper are published
separately (12). In line with previous research, we
hypothesised that acutely ill patients would present with
lower serum leptin concentrations when compared with
remitted patients. We also expected that altered serum
leptin levels would be correlated with Zn concentrations
(4, 5), in particular in the group of acutely ill patients.
Methods
Study sample
Forty-eight participants were enrolled in the study (for
characteristics see Table 1). The study sample and the
respective subgroups are identical to those used in
previous research studies (12). The present work focuses
on the interaction of serum Zn concentrations with
leptin, sOB-R and FLI.
Acutely ill patients (n14) met weight and diagnostic
criteria for AN (ICD-10, BMIB10th percentile or
BMIB17.5, with a mean duration of illness of 6.193.7
years). All subjects were administered the Structured
Interview for Anorexia and Bulimia Nervosa (SIAB)
(1315) and the Eating Disorders Inventory Symptom
Checklist (EDI-SC) (16). Secondary school students,
medical students and associated staff of a major mental
health service served as a control group (n15); they
did not display eating disorder symptoms and had
normal menses (12). Other co-morbid psychiatric dis-
orders were ruled out using clinical interviews. The
remitted patients (n19) were sent letters inviting them
to participate in the study. A BMI of at least 18 was
required for the group of remitted patients; all remitted
subjects were symptom-free based on the SIAB. More-
over, recovered patients needed to have maintained a
normal weight for at least 1 year prior (mean period of
recovery 6.092.7 years) without vomiting, binging, or
irregular menses (mean duration of regular menstruation
after amenorrhea during acute illness: 6.393.3 years;
mean duration of amenorrhea during acute illness: 11.29
10.5 months (12). Participants in the remitted group with
abnormal blood chemistry (e.g. serum thyroid hormones,
liver enzymes and electrolytes) were not included in the
analysis. Previous and current medical diseases were ruled
out using patient history, and acute as well as recent
infections met exclusion criteria for participation. Data
on the intake of dietary supplements as well as medica-
tions are provided in a different publication (12). Subjects
who took oral contraceptives did not differ from subjects
who did not in regard to serum Zn concentrations (12),
which was examined because the intake of oral contra-
ceptives has been associated with lower Zn concentra-
tions (17, 18). The study protocol was assessed and
approved by the Ethics Committee of the Faculty of
Medicine at J.W. Goethe University, Frankfurt am Main,
Germany. The investigation was carried out in accor-
dance with the Declaration of Helsinki.
Assessment
Blood samples from the healthy control group and the
remitted group were obtained during a single visit at
the above-mentioned mental health service (in addition,
assessment of weight, height, BMI, SIAB and EDI-SC
took place). Blood samples for the assessment of Zn
status in acutely ill patients were obtained following
admission. Trace mineralfree plastic tubes containing
2% sodium oxalate were used for blood sampling.
The obtained blood samples were then placed on ice.
An atomic absorption spectrophotometer (PerkinElmer,
Germany; intra-assay imprecision was between 2.7 and
3.2%, inter-assay imprecision was between 4.3 and 5.3%)
was used to determine serum Zn concentrations
(Johannes Gutenberg-University) (12). Other routine
laboratory tests (e.g. electrolytes, liver enzymes) were
F. D. Zepf et al.
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Citation: Food & Nutrition Research 2012, 56: 10941 - DOI: 10.3402/fnr.v56i0.10941Table 1. Characteristics of the control group (n15), acutely ill patients with anorexia nervosa (AN, n14) and remitted patients with AN (n19)
Healthy control
subjects (n15)
Acutely ill patients
with AN (n14)
Remitted patients
with AN (n19)
Controls vs.
acutely ill
patients
Controls vs.
remitted
patients
Acutely ill
vs. remitted
patients
M9SD Min. Max. M9SD Min. Max. M9SD Min. Max. p1 p2 p3
Age (years) 24.8092.78 20.42 29.91 20.7594.71 14.58 29.50 24.2493.31 17.42 29.91 0.008 ns 0.018
Weight (kg) 59.0696.18 50.00 71.30 45.9296.14 39.00 58.9 58.2296.00 50.10 70.80 0.000 ns 0.000
Height (cm) 167.4395.60 158 176 166.6396.95 157 181 165.5395.4 158 177 ns ns ns
BMI (kg/m
2) 21.0692.02 17.81 24.98 16.4591.26 13.68 16.45 21.1391.86 18.18 24.50 0.000 ns 0.000
Zinc (mg/dl) 59.95911.25 33.40 77.80 62.23913.78 40.30 89.50 81.75916.2 52.67 114 ns 0.000 0.001
Leptin (ng/ml) 10.1096.42 0.03 25.9 4.53 95.8 0.001 23.4 11.92 97.37 2.77 27.30 0.021** ns 0.004*
sOB-R (ng/ml) 18.9495.77 9.0 28.6 21.3096.77 13.4 34.4 24.7999.81 12.8 47.5 ns 0.051** ns
FLI 60.810
3948.610
3 0.110
374.70 159.610
3 24.610
3935.010
3 0.00510
3 141.810
3 54.310
3936.010
3 13.610
3 128.810
3 0.031** ns 0.027**
Data are presented with mean (M), minimum (Min.), maximum (Max.), and standard deviation (SD). Mean values were compared (t-tests, two-tailed) for significant differences between controls and acutely ill
patients with AN (p1), controls and remitted patients with AN (p2) and acutely ill patients with AN versus remitted patients with AN (p3).
sOB-R  soluble leptin receptor; FLI  free leptin index.
*Excellent power (0.99); **moderate power (0.80.9).
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)performed at the Department of Laboratory Medicine at
J.W. Goethe University in Frankfurt am Main.
Leptin
Leptin was measured by an in-house RIA (11, 19), with
intra-assay and inter-assay coefficients of variation lower
than 12.5% (range: 1 and 8 ng/ml). Recovery of dilution
experiments (undiluted to 1:20) was 88112% for the
concentration range between 4 and 6 ng/ml. Leptin levels
of the in-house RIA were comparable with the levels of
commercially available leptin RIA (Mediagnost, Tuebin-
gen, Germany) in the sera of normal-weight and obese
subjects.
sOB-R and FLI
Concentrations were determined by an in-house ligand-
immunofunctional assay (11). Briefly, microtiter plates
with anti-sOB-R IgG coated wells were used, with the
anti-sOB-R IgG having been raised in rabbits against
recombinant sOB-R (R&D, Wiesbaden, Germany). In-
cubation with PBS, 1% bovine serum albumin for 1 h at
room temperature was performed in order to block
potentially unspecific binding sites. Either rsOB-R stan-
dards (10 ml), ranging from 6.25 and 100 ng/ml, or the
serum samples were added to the wells. The rsOB-R
standards were incubated overnight at 48C with an excess
of biotinylated leptin in assay buffer (1% rabbit globulin,
0.1% BSA and 0.05% Tween 20 in PBS). An established
recombinant sOB-R preparation was used for calibration
purposes (11, 20). A parallel course between rsOB-R and
native sOB-R was found. Europium-labeled streptavidin
(PerkinElmer, Germany) was used to detect the complex
of biotinylated leptin and sOB-R. The plate was washed
with PBS (0.05% Tween 20) each time between coating,
blocking, incubation and detection. The Victor-system
(PerkinElmer, Germany) was used to measure the solid
phase-linked fluorescence signal of Europium. The re-
sulting signal was dependent on both immunological
recognition of the sOB-R and leptin binding. Intra-assay
and inter-assay coefficients of variation for two of the
control samples were lower than 11.7%. As was shown
previously, the assay used was nearly insensitive to the
interference of leptin (11).
The free leptin index (FLI) was determined by
calculating the ratio of the levels of leptin to sOB-R,
multiplied by 100.
Zn
As reported previously, trace mineral-free plastic tubes
containing 2% sodium oxalate were used to collect
blood samples and then placed on ice (12). An atomic
absorption spectrophotometer (PerkinElmer, Germany)
was used to assess serum Zn concentrations.
Data analysis
The PASW Statistics 18 softwarepackage (SPSS, Chicago,
USA) was used for data analysis. Serum leptin concen-
trations, sOB-R and FLI were normally distributed
(Kolmogorov-Smirnov goodness of fit test). Statistical
significance was assumed for pB0.05. t-tests (two-tailed)
were implemented for between-group comparisons.
Pearson correlations (two-tailed) were used for additional
dimensional analyses in regard to correlations between Zn
concentrations and leptin, sOB-Rand FLI in the different
subgroups. Because of the explorative nature of this
investigation, significant p-values were not subjected to
alpha-adjustment to avoid overlooking potential effects
and interactions. The data on Zn concentrations had been
previously subjected to alpha-adjustment (12) in accor-
dance with the BonferroniHolm procedure (21). Ad-
justed p-values in regard to Zn concentrations are
indicated by padj.
Results
Comparison of subgroups
Acutely ill versus remitted
Serum leptin concentrations (t3.108, F 4.338,
p 0.004, df 1,31) and FLI (t2.329, F 1.578,
p 0.027, df1,30) were higher in remitted subjects
compared with acutely ill patients, but there were no
differences in sOB-R concentrations between those two
subgroups (see Table 1, Fig. 1ac). As previously men-
tioned, remitted AN patients with had significantly
higher serum Zn levels compared with the acutely
ill AN patients (t  3.642, F 0.522, padj 0.002,
df 1,31; see Fig. 1d and (12)).
Remitted versus controls
There was nearly a statistically significant difference in
sOB-R concentrations (t  2.031, F 4.565, p 
0.051, df 1,31), with remitted patients showing higher
sOB-R concentrations (see Fig. 1b). There were no
differences in FLI concentrations between controls and
remitted patients (t 0.440, F 0.906, p  0.05, df
1,31; see also Fig. 1c). Remitted AN patients had
significantly higher Zn levels than the control subjects
(t4.435, F 2.427, padj 0.000, df1,32; see
Fig. 1d and (12)).
Acutely ill versus controls
As shown in Fig. 1a and c, serum leptin concentrations
(t 2.447, F1.310, p 0.021, df1,27) and FLI were
higher in control subjects compared with acutely ill AN
patients (t 2.276, F 2.905, p 0.031, df1,27).
There was no significant difference in Zn serum levels
between acutely ill patients and controls (t0.490,
F 0.644, p 0.05, df1,27; see Fig. 1d and (12)).
F. D. Zepf et al.
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Controls
Serum Zn concentrations were not correlated with
serum leptin (rxy0.114; p 0.05), sOB-R (rxy 
0.091; p  0.05) or FLI (rxy0.173; p  0.05).
AN acutely ill
Zn concentrations were not correlated with serum
leptin (rxy 0.253; p  0.05), sOB-R (rxy0.006;
p  0.05) or FLI (rxy 0.229; p  0.05).
AN remitted
There were no correlations between serum Zn con-
centrations and serum leptin (rxy 0.200; p  0.05),
sOB-R (rxy0.158; p  0.05) or FLI (rxy 0.342;
p  0.05).
Post-hoc power analysis (for a significance level [alpha] of
0.05, two-tailed)
In order to estimate sample sizes for future large-scale
studies, we calculated the power of the present study after
completion.
Leptin
The experiment had a power of 0.60 to detect the
smallest average difference in serum leptin concentrations
(5.21 ng/ml) between pairs of controls (n15) and
acutely ill patients (n14); the difference between con-
trols and acutely ill patients was found to be 5.56 ng/ml.
We also estimated the statistical power with respect to
the limitations of the intra- and interassay variance.
To detect a difference between means of 3.40 ng/ml
[a difference calculated for a mean in the control group of
Fig. 1. Serum concentrations obtained in adolescents and young adults of (a) leptin (ng/ml), (b) the soluble leptin receptor
(sOB-R, ng/ml), (c) free leptin index (FLI) and (d) zinc (Zn, mg/dl) with mean and SD for acutely ill (n14) and recovered
patients (n15) with anorexia nervosa (AN) and for healthy controls (n19).
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and a mean of 5.80 ng/ml for acutely ill patients (actual
mean value of 4.53 ng/ml12.5%)] an adjusted power of
0.30 was calculated post-hoc. Future studies should take
such limitations into account with respect to the used
assay. When comparing remitted patients and controls, a
power of 0.85 was calculated, detecting a difference
between means of 7.46 ng/ml (the found difference was
7.39 ng/ml). For the comparison of remitted and acutely
ill patients, a power of 0.10 was calculated to detect a
difference between means of 1.67 ng/ml (the found
difference was 1.83 ng/ml). Consequently, the present
study had good power to detect differences in the means
between controls and remitted patients, and only moder-
ate power to detect differences between controls and
acutely ill patients. However, the present study was
underpowered in regard to the comparison of remitted
patients and acutely ill patients.
FLI
In regard to FLI, the study had a power of 0.60 to detect
a smallest average difference between pairs of 36.410
3
between controls and acutely ill patients (the difference
found was 36.310
3). A power of 0.6 was also
calculated to detect a smallest difference between pairs
of 28.710
3 (the difference was 30.010
3) between
remitted and acutely ill patients. For the comparison
between remitted patients and controls, a power of 0.10
was calculated to detect a difference between means of
10.210
3 (but the difference was discovered to be 6.5
10
3). With this in mind, with respect to FLI, the present
study had moderate power to detect significant differ-
ences in means between controls and acutely ill patients,
as well as between acutely ill and remitted patients.
However, in regard to the FLI comparison between
remitted patients and controls, the present study was
underpowered.
sOB-R
The study had a power of 0.50 to detect a smallest
difference between means of control and remitted sub-
jects of 5.80 ng/ml (the difference found was 5.85 ng/ml).
When comparing acutely ill and remitted patients, a
power of 0.2 was calculated to detect a difference
between pairs of 3.54 ng/ml (the difference found was
3.49 ng/ml). For the comparison of acutely ill patients
and controls, a power of 0.20 was calculated to detect a
difference between these groups of 2.71 ng/ml (the
difference found was 2.36 ng/nl). As a consequence, the
present study only had low moderate power to detect
differences between controls and remitted patients, but
was underpowered in finding differences between acutely
ill and remitted patients, as well as acutely ill patients and
controls.
Discussion
Along with data from previous research, the main results
of the present work are:
1. Serum leptin levels and FLI, as well as serum Zn
concentrations  mainly due to dietary preferences
as regards Ca
2 and phosphorus containing foods
(12)  were higher in remitted AN subjects compared
with acutely ill patients.
2. Remitted patients showed significantly higher con-
centrations of the sOB-R but no difference in FLI
when compared with healthy controls (while re-
mitted patients were shown to have higher serum
Zn concentrations).
3. Serum leptin levels and FLI were lower in acutely ill
patients compared with controls, who displayed no
differences in serum Zn concentrations. Addition-
ally, serum Zn concentrations were not correlated
with serum leptin, sOB-R or FLI concentrations in
any of the three investigated subgroups (acutely ill
patients, remitted patients and controls).
The present data are in line with previous research on
the leptin state in AN showing lowered leptin concentra-
tions in acutely ill patients with AN, and that weight
gain is associated with increased leptin levels or even
hyperleptinaemia (22). However, the association between
the stage and state of AN (i.e. acutely ill vs. remitted)
in humans and changed serum leptin levels, FLI
and Zn concentrations is not clear, particularly with
respect to animal data obtained in rats suggesting that
leptin expression may be directly affected by Zn (8).
The data of the present investigation do not entirely
support an association between serum Zn concentrations
and different indices of the leptin axis, in particular
because there were no significant correlations between
serum Zn and leptin, sOB-R and FLI in any subgroup.
In our study, remitted patients showed elevated serum
leptin levels; because of this, FLI and Zn concentrations
might be considered indicative of such a relationship,
with respect to the stage of illness in younger patient
populations.
However, the data provided by the present study must
be considered preliminary, in particular because differ-
ences in serum Zn concentrations are likely to depend on
reported food preferences (12). In addition, research
proposing decreased food intake, rather than Zn defi-
ciency itself, being associated with changes in plasma
leptin availability in Zn-deficient rats must be mentioned
here (9, 10). Accordingly, these findings assume that low
serum leptin concentrations, hypometabolism and dimin-
ished activity levels are more likely the result of anorexia
per se than of Zn deficiency alone (9, 10). Notably, in our
study, remitted patients showed higher sOB-R and
Zn concentrations when compared with healthy controls,
F. D. Zepf et al.
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no difference in sOB-R concentrations observed between
acutely ill and remitted patients with AN. Following this,
more studies with larger samples are warranted in order
to further investigate if changes in leptin expression are
associated with differences in serum Zn status in patients
with AN.
Unambiguous clinical conclusions cannot be drawn
from the present study. However, if the finding that
remitted patients with AN showed increased serum Zn,
FLI and leptin concentrations could be replicated in
future large-scale studies, one could speculate that leptin
expression is associated with altered serum Zn status in
remitted patients; this would somewhat align with the
aforementioned animal data (8). One could speculate that
changed leptin expression in response to normalised or
even elevated Zn concentrations in remitted patients,
which is likely to be influenced by dietary factors (12),
might reflect an adaptive mechanism with respect to the
state of the illness, possibly in order to prevent relapse.
However, such assumptions remain speculative at this
stage. Randomised double-blind placebo-controlled trials
with Zn supplementation and determination of serum
leptin, sOB-R concentrations and FLI, also involving
longitudinal follow-up assessments of the outlined para-
meters and clinical symptoms, would be necessary in
order to address this question.
The present study is subject to limitations. In regard to
the noted significant differences between groups, only the
reported difference in leptin concentrations between
remitted and acutely ill patients had insufficient statistical
power; on the other hand, moderate power was calculated
for the group differences between control subjects and
acutelyill patients(leptin,FLI), aswellaslowtomoderate
power for remitted patients versus controls (sOB-R) and
remitted versus acutely ill patients (FLI). Apart from the
limited sample size (12), it must also be noted that within
the group of acutely ill patients, blood samples were
obtained at different BMI stages. To overcome this
limitation, one would need a sample of patients with
nearly equal BMIs upon admission, which is difficult to
coordinate as patients generally present in different stages
of the illness (and due to this, they display different BMI
values upon admission) upon entry to clinical depart-
ments andsubsequentinpatient treatment. Inaddition, no
data on body fat and energy intake, in particular as
regards the total quantity of food intake, were obtained.
These aspects should be assessed in future studies, and the
present data need to be replicated in larger samples.
In summary, the present study investigated the rela-
tionship between serum Zn concentrations and para-
meters of the leptin axis (sOB-R, FLI) in adolescent and
young adult humans with AN. However, the relationship
between the leptin axis and Zn concentrations remains
unclear, in particular due to limited statistical power;
some of the comparisons investigated only higher leptin
concentrations in remitted patients compared with
acutely ill patients, which parallel the higher serum Zn
concentrations in remitted versus acutely ill patients.
Because recent research has indicated that elevated serum
Zn concentrations in remitted patients were likely due to
dietary preferences (12), the relationship between changes
in the leptin axis, as well as in serum Zn levels, should be
further elucidated, in particular with respect to the stage
of the illness. Altered concentrations of Zn, leptin and
FLI in remitted AN patients compared with acutely ill
patients, with respect to healthy controls, need to be
replicated using larger sample sizes. The present study
provides an estimate for recommended sample sizes in
regard to this type of future large-scale research.
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